QR код

Characterization of JNJ-80948543 a novel CD79bxCD20xCD3 trispecific antibody for B-cell non-Hodgkin lymphoma

Despite advances in targeted therapies, relapsed/refractory B-cell non-Hodgkin lymphoma (R/R B-NHL) remains incurable in the majority of patients. Thus, there is a critical need to expand the treatment options for R/R B-NHL to improve patient outcomes. In this study, we characterized JNJ-80948543,...

Повний опис

Збережено в:
Автори: Anna Kuchnio, Danlin Yang, Nele Vloemans, Ivo Cornelissen, Ricardo Amorim, Tatiana Perova, Cassandra Lowenstein, Lut Janssen, Toon Suls, Mariette Bekkers, Elena Lasorsa, Lorena Fontan, Neeharika Nemani, Taylor Hojnacki, Chao Han, Siddharth Sukumaran, Nicole Medeiros, Srimathi Srinivasan, Bingyuan Wu, Jun Chen, Michael D. Feldkamp, Sam Wu, Habtom Habte, Autumn J. McRee, Nikki Daskalakis, John Krayer, Cam Holland, Ricardo Attar, Phillip M. DeYoung, Sanjaya Singh, Yusri Elsayed, Ulrike Philippar
Формат: Artigo
Мова:Inglês
Опубліковано: Ferrata Storti Foundation 2026-02-01
Серія:Haematologica
Онлайн доступ:https://haematologica.org/article/view/13176
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси